{"entity":{"type":"insider","cik":"0001638744","url":"/insider/0001638744","json_url":"/insider/0001638744.json","name":"Ng George K","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":16,"first":"2015-08-05","last":"2026-07-01","span_basis":"filed_date"},"name_variants":[{"name":"Ng George K","source":"filing","n_filings":16,"first_seen":"2015-08-05","last_seen":"2026-07-01"}],"transactions":[{"id":6012873,"accession":"0000897069-26-001480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001480","line_url":"/filing/0000897069-26-001480#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3057.0,"shares_display":"3,057","price_per_share":1.93,"price_display":"1.93","price_state":"stated","total_value":5900.01,"total_display":"5,900.01","total_whole":"5,900","shares_owned_after":15492.0,"shares_owned_after_display":"15,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-01","scope":"insider"},{"id":6029407,"accession":"0000897069-26-001410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001410","line_url":"/filing/0000897069-26-001410#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2465.0,"shares_display":"2,465","price_per_share":2.22,"price_display":"2.22","price_state":"stated","total_value":5472.3,"total_display":"5,472.30","total_whole":"5,472","shares_owned_after":12435.0,"shares_owned_after_display":"12,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-16","scope":"insider"},{"id":5768175,"accession":"0000897069-26-001291","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001291","line_url":"/filing/0000897069-26-001291#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2129.0,"shares_display":"2,129","price_per_share":2.57,"price_display":"2.57","price_state":"stated","total_value":5471.53,"total_display":"5,471.53","total_whole":"5,472","shares_owned_after":9970.0,"shares_owned_after_display":"9,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-29","filed_date":"2026-06-01","scope":"insider"},{"id":6069574,"accession":"0000897069-26-001186","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001186","line_url":"/filing/0000897069-26-001186#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1843.0,"shares_display":"1,843","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":5473.71,"total_display":"5,473.71","total_whole":"5,474","shares_owned_after":7841.0,"shares_owned_after_display":"7,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-19","scope":"insider"},{"id":5832033,"accession":"0000897069-26-001006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001006","line_url":"/filing/0000897069-26-001006#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2034.0,"shares_display":"2,034","price_per_share":2.69,"price_display":"2.69","price_state":"stated","total_value":5471.46,"total_display":"5,471.46","total_whole":"5,471","shares_owned_after":6013.0,"shares_owned_after_display":"6,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-30","filed_date":"2026-05-01","scope":"insider"},{"id":9203490,"accession":"0000897069-26-001167","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001167","line_url":"/filing/0000897069-26-001167#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1843.0,"shares_display":"1,843","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":5473.71,"total_display":"5,473.71","total_whole":"5,474","shares_owned_after":3979.0,"shares_owned_after_display":"3,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-05-19","scope":"insider"},{"id":9203489,"accession":"0000897069-26-000979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-000979","line_url":"/filing/0000897069-26-000979#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1843.0,"shares_display":"1,843","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":5473.71,"total_display":"5,473.71","total_whole":"5,474","shares_owned_after":3979.0,"shares_owned_after_display":"3,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-30","scope":"insider"},{"id":6163955,"accession":"0000897069-26-000910","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-000910","line_url":"/filing/0000897069-26-000910#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1843.0,"shares_display":"1,843","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":5473.71,"total_display":"5,473.71","total_whole":"5,474","shares_owned_after":5492.0,"shares_owned_after_display":"5,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-17","scope":"insider"},{"id":9203488,"accession":"0000897069-26-000977","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-000977","line_url":"/filing/0000897069-26-000977#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2136.0,"shares_display":"2,136","price_per_share":2.535,"price_display":"2.54","price_state":"stated","total_value":5414.76,"total_display":"5,414.76","total_whole":"5,415","shares_owned_after":2136.0,"shares_owned_after_display":"2,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-04-30","scope":"insider"},{"id":5738443,"accession":"0000897069-26-000750","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-000750","line_url":"/filing/0000897069-26-000750#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2136.0,"shares_display":"2,136","price_per_share":2.535,"price_display":"2.54","price_state":"stated","total_value":5414.76,"total_display":"5,414.76","total_whole":"5,415","shares_owned_after":3649.0,"shares_owned_after_display":"3,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-04-01","scope":"insider"},{"id":4522317,"accession":"0000897069-25-000134","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-25-000134","line_url":"/filing/0000897069-25-000134#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":87200.0,"shares_display":"87,200","price_per_share":0.7975,"price_display":"0.80","price_state":"stated","total_value":69542.0,"total_display":"69,542.00","total_whole":"69,542","shares_owned_after":87200.0,"shares_owned_after_display":"87,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-27","filed_date":"2025-01-29","scope":"insider"},{"id":2035061,"accession":"0000897069-24-000229","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-24-000229","line_url":"/filing/0000897069-24-000229#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.7,"price_display":"2.70","price_state":"stated","total_value":27000.0,"total_display":"27,000.00","total_whole":"27,000","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-30","filed_date":"2024-01-31","scope":"insider"},{"id":6406500,"accession":"0000850261-18-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000850261-18-000010","line_url":"/filing/0000850261-18-000010#line-2","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":90000.0,"shares_display":"90,000","price_per_share":9.95,"price_display":"9.95","price_state":"stated","total_value":895500.0,"total_display":"895,500.00","total_whole":"895,500","shares_owned_after":101453.0,"shares_owned_after_display":"101,453","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-28","filed_date":"2018-02-28","scope":"insider"},{"id":4967179,"accession":"0000899243-17-002781","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-002781","line_url":"/filing/0000899243-17-002781#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":206000.0,"total_display":"206,000.00","total_whole":"206,000","shares_owned_after":49338.0,"shares_owned_after_display":"49,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-03","filed_date":"2017-02-03","scope":"insider"},{"id":8437120,"accession":"0000899243-15-003751","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-15-003751","line_url":"/filing/0000899243-15-003751","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":888.0,"shares_display":"888","price_per_share":13.501709459459459,"price_display":"13.50","price_state":"stated","total_value":11989.518,"total_display":"11,989.52","total_whole":"11,990","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-21","filed_date":"2015-08-21","scope":"insider","n_lines":3},{"id":8894652,"accession":"0000899243-15-002428","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-002428","line_url":"/filing/0000899243-15-002428#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001638744","owner_name":"Ng George K","owner_display_name":"Ng George K","owner_url":"/insider/0001638744","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11453.0,"shares_display":"11,453","price_per_share":11.5,"price_display":"11.50","price_state":"stated","total_value":131709.5,"total_display":"131,709.50","total_whole":"131,710","shares_owned_after":14901.0,"shares_owned_after_display":"14,901","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-08-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":17,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001533743","name":"Processa Pharmaceuticals, Inc.","url":"/issuer/0001533743","role":"Director, Officer (Chief Executive Officer)","n_filings":12,"first_seen":"2024-01-31","last_seen":"2026-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0000850261","name":"Sorrento Therapeutics, Inc.","url":"/issuer/0000850261","role":"Officer","n_filings":4,"first_seen":"2015-08-05","last_seen":"2018-02-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001638744","retrieved_at":"2026-08-24T14:03:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}